Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
25.00
-0.80 (-3.10%)
At close: May 15, 2026, 4:00 PM EDT
25.10
+0.10 (0.40%)
After-hours: May 15, 2026, 7:35 PM EDT
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.45 billion as of May 15, 2026. Its market cap has decreased by -31.90% in one year.
Market Cap
2.45B
Enterprise Value
3.12B
1-Year Change
-31.90%
Ranking
Category
Stock Price
$25.00
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.45B, an increase of 106.47%. That is a compound annual growth rate of 6.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.46B | 10.96% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 2.74B |
| Structure Therapeutics | 2.70B |
| Disc Medicine | 2.64B |
| Enliven Therapeutics | 2.58B |
| Celldex Therapeutics | 2.55B |
| IDEAYA Biosciences | 2.53B |
| Nanobiotix | 2.50B |
| Nektar Therapeutics | 2.50B |